“06 | Nirsevimab As a Key Strategy to Prevent Respiratory Syncytial Virus Among Newborns and Children: Real-World Evidence from Italy and Sicily”. EuroMediterranean Biomedical Journal, vol. 21, no. s1, Nov. 2026, https://doi.org/10.3269/q1nt4g06.